RC
CVS icon

Randolph Company’s CVS Health CVS Stock Holding History

Randolph Company’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-275,313
Closed -$17.3M – 47
2024
Q3 		$17.3M Sell
275,313
-1,186
-0.4% -$69.2K 2.01% 24
2024
Q2 		$16.3M Buy
276,499
+432
+0.2% +$27K 2% 24
2024
Q1 		$22M Sell
276,067
-749
-0.3% -$57.2K 2.7% 22
2023
Q4 		$21.9M Buy
276,816
+339
+0.1% +$24.1K 2.91% 19
2023
Q3 		$19.3M Sell
276,477
-1,069
-0.4% -$75.7K 3.1% 16
2023
Q2 		$19.2M Sell
277,546
-344
-0.1% -$24.5K 2.67% 21
2023
Q1 		$20.7M Buy
277,890
+1,135
+0.4% +$95.2K 2.99% 18
2022
Q4 		$25.8M Hold
276,755
– – 3.95% 7
2022
Q3 		$26.4M Sell
276,755
-53
-0% -$5.25K 4.18% 4
2022
Q2 		$25.6M Hold
276,808
– – 3.88% 9
2022
Q1 		$28M Hold
276,808
– – 3.6% 11
2021
Q4 		$28.6M Sell
276,808
-244
-0.1% -$22.5K 3.44% 11
2021
Q3 		$23.5M Buy
277,052
+1,176
+0.4% +$98.5K 3.02% 17
2021
Q2 		$23M Hold
275,876
– – 2.99% 17
2021
Q1 		$20.8M Hold
275,876
– – 2.83% 17
2020
Q4 		$18.8M Hold
275,876
– – 2.8% 19
2020
Q3 		$16.1M Sell
275,876
-317
-0.1% -$19.7K 2.77% 21
2020
Q2 		$17.9M Sell
276,193
-50
-0% -$3.15K 3.21% 16
2020
Q1 		$16.4M Buy
+276,243
New +$18.4M 3.25% 15
2018
Q4 		– Sell
-279,395
Closed -$22M – 36
2018
Q3 		$22M Buy
279,395
+91,100
+48% +$6.51M 3.66% 10
2018
Q2 		$12.1M Buy
188,295
+92,235
+96% +$6.08M 2.24% 21
2018
Q1 		$5.98M Buy
+96,060
New +$6.89M 1.09% 33
2016
Q3 		– Sell
-159,140
Closed -$15.2M – 33
2016
Q2 		$15.2M Hold
159,140
– – 3.92% 15
2016
Q1 		$16.5M Buy
+159,140
New +$15.5M 3.68% 13

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Randolph Company's CVS Position: Q4 2024 in Review

Randolph Company sold out of CVS Health (CVS) in Q4 2024, closing a stake of 275,313 shares — an estimated $17.3M sold.

Randolph Company first reported a position in CVS in Q1 2016 and held it in 24 quarters. The position peaked at $28.6M in Q4 2021. 1,668 funds tracked by Wall St. Rank hold CVS as of Q4 2024.

  • Randolph Company reported no remaining CVS Health position as of Q4 2024 after selling out during the quarter.
  • Randolph Company sold 275,313 CVS Health shares in Q4 2024, an estimated $17.3M.
  • Randolph Company first reported a position in CVS Health in Q1 2016 and held it in 24 quarters.
  • Randolph Company's CVS Health position peaked at $28.6M in Q4 2021.
  • 1,668 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.

Based on Randolph Company's 13F filing for Q4 2024, filed 14 Feb 2025.